{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T07:10:01Z","timestamp":1760080201942},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2018,7,27]],"date-time":"2018-07-27T00:00:00Z","timestamp":1532649600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2018,7,27]],"date-time":"2018-07-27T00:00:00Z","timestamp":1532649600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"Giulini SpA"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dermatol Ther (Heidelb)"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1007\/s13555-018-0252-3","type":"journal-article","created":{"date-parts":[[2018,7,27]],"date-time":"2018-07-27T08:56:01Z","timestamp":1532681761000},"page":"455-462","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["A Single-Arm, Open-Label, Phase IV Study to Evaluate the Efficacy of a Topical Formulation for Hyperkeratotic Actinic Keratosis Lesions"],"prefix":"10.1007","volume":"8","author":[{"given":"Maria Pia","family":"De Padova","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara","family":"Marzani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela","family":"Pinto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabio","family":"Rinaldi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,7,27]]},"reference":[{"issue":"3","key":"252_CR1","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1111\/jdv.14753","volume":"32","author":"MA Richard","year":"2018","unstructured":"Richard MA, Amici JM, Basset-Seguin N, Claudel JP, Cribier B, Dreno B. Management of actinic keratosis at specific body sites in patients at high risk of carcinoma lesions: expert consensus from the AKTeam\u2122 of expert clinicians. J Eur Acad Dermatol Venereol. 2018;32(3):339\u201346.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"3","key":"252_CR2","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1111\/bjd.12420","volume":"169","author":"RN Werner","year":"2013","unstructured":"Werner RN, Sammain A, Erdmann R, Hartmann V, Stockfleth E, Nast A. The natural history of actinic keratosis: a systematic review. Br J Dermatol. 2013;169(3):502\u201318.","journal-title":"Br J Dermatol"},{"issue":"Suppl 2","key":"252_CR3","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1111\/jdv.14152","volume":"31","author":"G Goldenberg","year":"2017","unstructured":"Goldenberg G. Treatment considerations in actinic keratosis. J Eur Acad Dermatol Venereol. 2017;31(Suppl 2):12\u20136.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"2","key":"252_CR4","doi-asserted-by":"publisher","first-page":"168","DOI":"10.2174\/1872213X11307020008","volume":"7","author":"C Cantisani","year":"2013","unstructured":"Cantisani C, De Gado F, Ulrich M, Bottoni U, Iacobellis F, Richetta AG, Calvieri S. Actinic keratosis: review of the literature and new patents. Recent Pat Inflamm Allergy Drug Discov. 2013;7(2):168\u201375.","journal-title":"Recent Pat Inflamm Allergy Drug Discov."},{"issue":"5 Pt 1","key":"252_CR5","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1016\/0190-9622(91)70113-G","volume":"24","author":"EA Olsen","year":"1991","unstructured":"Olsen EA, Abernethy ML, Kulp-Shorten C, Callen JP, Glazer SD, Huntley A, McCray M, Monroe AB, Tschen E, Wolf JE Jr. A double-blind, vehicle-controlled study evaluating masoprocol cream in the treatment of actinic keratoses on the head and neck. J Am Acad Dermatol. 1991;24(5 Pt 1):738\u201343.","journal-title":"J Am Acad Dermatol"},{"issue":"Suppl 2","key":"252_CR6","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1111\/j.1365-2133.2007.08267.x","volume":"157","author":"J Roewert-Huber","year":"2007","unstructured":"Roewert-Huber J, Stockfleth E, Kerl H. Pathology and pathobiology of actinic (solar) keratosis\u2014an update. Br J Dermatol. 2007;157(Suppl 2):18\u201320.","journal-title":"Br J Dermatol"},{"issue":"8","key":"252_CR7","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1111\/jdv.13626","volume":"30","author":"L Schmitz","year":"2016","unstructured":"Schmitz L, Kahl P, Majores M, Bierhoff E, Stockfleth E, Dirschka T. Actinic keratosis: correlation between clinical and histological classification systems. J Eur Acad Dermatol Venereol. 2016;30(8):1303\u20137.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"6","key":"252_CR8","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1111\/j.1365-2133.1986.tb06644.x","volume":"115","author":"R Marks","year":"1986","unstructured":"Marks R, Foley P, Goodman G, Hage BH, Selwood TS. Spontaneous remission of solar keratoses: the case for conservative management. Br J Dermatol. 1986;115(6):649\u201355.","journal-title":"Br J Dermatol"},{"issue":"2","key":"252_CR9","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1046\/j.1523-1747.2000.00048.x","volume":"115","author":"C Frost","year":"2000","unstructured":"Frost C, Williams G, Green A. High incidence and regression rates of solar keratoses in a Queensland community. J Invest Dermatol. 2000;115(2):273\u20137.","journal-title":"J Invest Dermatol."},{"issue":"9","key":"252_CR10","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1111\/jdv.12434","volume":"28","author":"B Dr\u00e9no","year":"2014","unstructured":"Dr\u00e9no B, Amici JM, Basset-Seguin N, Cribier B, Claudel JP. Richard MA; AKTeam\u2122. Management of actinic keratosis: a practical report and treatment algorithm from AKTeam\u2122 expert clinicians. J Eur Acad Dermatol Venereol. 2014;28(9):1141\u20139.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"Suppl 5","key":"252_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1468-3083.2011.04296.x","volume":"25","author":"JJ Bonerandi","year":"2011","unstructured":"Bonerandi JJ, Beauvillain C, Caquant L, Chassagne JF, Chaussade V, Clav\u00e8re P, Desouches C, Garnier F, Grolleau JL, Grossin M, Jourdain A, Lemonnier JY, Maillard H, Ortonne N, Rio E, Simon E, Sei JF, Grob JJ, Martin L, French Dermatology Recommendations Association (aRED). Guidelines for the diagnosis and treatment of cutaneous squamous cell carcinoma and precursor lesions. J Eur Acad Dermatol Venereol. 2011;25(Suppl 5):1\u201351.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"3","key":"252_CR12","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/j.jaad.2009.07.026","volume":"63","author":"EE Uhlenhake","year":"2010","unstructured":"Uhlenhake EE, Sangueza OP, Lee AD, Jorizzo JL. Spreading pigmented actinic keratosis: a review. J Am Acad Dermatol. 2010;63(3):499\u2013506. https:\/\/doi.org\/10.1016\/j.jaad.2009.07.026.","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"252_CR13","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1111\/jdv.12856","volume":"30","author":"JM Tan","year":"2016","unstructured":"Tan JM, Sinnya S, Soyer HP. The ratio of non-hyperkeratotic and hyperkeratotic actinic keratosis in a high-risk non-melanoma skin cancer cohort in Queensland. J Eur Acad Dermatol Venereol. 2016;30(3):473\u20134.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"5","key":"252_CR14","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1111\/jdv.12031","volume":"27","author":"CA Morton","year":"2013","unstructured":"Morton CA, Szeimies RM, Sidoroff A, Braathen LR. European guidelines for topical photodynamic therapy part 1: treatment delivery and current indications\u2014actinic keratoses, Bowen\u2019s disease, basal cell carcinoma. J Eur Acad Dermatol Venereol. 2013;27(5):536\u201344.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"1","key":"252_CR15","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s13555-015-0070-9","volume":"5","author":"P Chetty","year":"2015","unstructured":"Chetty P, Choi F, Mitchell T. Primary care review of actinic keratosis and its therapeutic options: a global perspective. Dermatol Ther (Heidelb). 2015;5(1):19\u201335.","journal-title":"Dermatol Ther (Heidelb)."},{"key":"252_CR16","doi-asserted-by":"crossref","unstructured":"Korman N, Moy R, Ling M, Matheson R, Smith S, McKane S, Lee JH. Dosing with 5% imiquimod cream 3 times per week for the treatment of actinic keratosis: results of two phase 3, randomized, double-blind, parallel-group, vehicle-controlled trials. Arch Dermatol. 2005;141(4):467\u201373.","DOI":"10.1001\/archderm.141.4.467"},{"issue":"4","key":"252_CR17","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/j.jaad.2004.02.022","volume":"51","author":"RM Szeimies","year":"2004","unstructured":"Szeimies RM, Gerritsen MJ, Gupta G, Ortonne JP, Serresi S, Bichel J, Lee JH, Fox TL, Alomar A. Imiquimod 5% cream for the treatment of actinic keratosis: results from a phase III, randomized, double-blind, vehicle-controlled, clinical trial with histology. J Am Acad Dermatol. 2004;51(4):547\u201355.","journal-title":"J Am Acad Dermatol"},{"issue":"8","key":"252_CR18","doi-asserted-by":"publisher","first-page":"e104045","DOI":"10.1371\/journal.pone.0104045","volume":"9","author":"S Briganti","year":"2014","unstructured":"Briganti S, Flori E, Bellei B, Picardo M. Modulation of PPAR\u03b3 provides new insights in a stress induced premature senescence model. PLoS One. 2014;9(8):e104045.","journal-title":"PLoS One"},{"key":"252_CR19","doi-asserted-by":"crossref","unstructured":"Flori E, Mastrofrancesco A, Kovacs D, Bellei B, Briganti S, Maresca V, Cardinali G, Picardo M. The activation of PPAR\u03b3 by 2,4,6-octatrienoic acid protects human keratinocytes from UVR-induced damages. Sci Rep. 2017;7(1):9241.","DOI":"10.1038\/s41598-017-09578-3"},{"key":"252_CR20","doi-asserted-by":"publisher","DOI":"10.23736\/S0392-0488.18.06064-9","author":"M Lombardi","year":"2018","unstructured":"Lombardi M, Rossi A, Fortuna MC, Garelli V, Sama E, Senis D, et al. Treatment of facial actinic keratoses with a cream containing octatrienoic acid: a multi center clinical experience. G Ital Dermatol Venereol. 2018. https:\/\/doi.org\/10.23736\/S0392-0488.18.06064-9.","journal-title":"G Ital Dermatol Venereol"}],"container-title":["Dermatology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-018-0252-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13555-018-0252-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-018-0252-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,23]],"date-time":"2024-08-23T11:29:37Z","timestamp":1724412577000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13555-018-0252-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,27]]},"references-count":20,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["252"],"URL":"https:\/\/doi.org\/10.1007\/s13555-018-0252-3","relation":{},"ISSN":["2193-8210","2190-9172"],"issn-type":[{"type":"print","value":"2193-8210"},{"type":"electronic","value":"2190-9172"}],"subject":[],"published":{"date-parts":[[2018,7,27]]},"assertion":[{"value":"20 June 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 July 2018","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}